Reduced density of calbindin immunoreactive GABAergic neurons in the occipital cortex in major depression: relevance to neuroimaging studies
- PMID: 20004363
- PMCID: PMC2823848
- DOI: 10.1016/j.biopsych.2009.10.027
Reduced density of calbindin immunoreactive GABAergic neurons in the occipital cortex in major depression: relevance to neuroimaging studies
Abstract
Background: Several lines of evidence suggest dysfunction of the gamma-aminobutyric acid (GABA)ergic system in major depressive disorder. Neuroimaging studies report reduced levels of GABA in the dorsolateral prefrontal and occipital cortex of depressed patients. Our previous postmortem study revealed a reduction in the density and size of calbindin-immunoreactive (CB-IR) GABAergic neurons in the prefrontal cortex in major depressive disorder. The goal of this study was to test whether the changes in CB-IR neurons can also be detected in the occipital cortex, where neuroimaging studies report a prominent GABA decrease.
Methods: A three-dimensional cell counting probe was used to assess the cell-packing density and size of CB-IR neurons in layer II of the occipital cortex in 10 major depressive disorder subjects and 10 psychiatrically healthy control subjects.
Results: The density of CB-IR neurons was significantly decreased by 28% in major depressive disorder subjects compared with the control group. The size of CB-IR neurons was unchanged in major depressive disorder subjects when compared with control subjects.
Conclusions: The reduction in the density of CB-IR GABAergic neurons in the occipital cortex in depression is similar to that observed previously in the prefrontal cortex. Deficit in cortical GABAergic interneurons may contribute to the low GABA levels detected in neuroimaging studies in major depressive disorder patients.
Copyright 2010 Society of Biological Psychiatry. Published by Elsevier Inc. All rights reserved.
Figures
![Figure 1](https://cdn.statically.io/img/www.ncbi.nlm.nih.gov/pmc/articles/instance/2823848/bin/nihms156136f1.gif)
![Figure 2](https://cdn.statically.io/img/www.ncbi.nlm.nih.gov/pmc/articles/instance/2823848/bin/nihms156136f2.gif)
![Figure 3](https://cdn.statically.io/img/www.ncbi.nlm.nih.gov/pmc/articles/instance/2823848/bin/nihms156136f3.gif)
![Figure 4](https://cdn.statically.io/img/www.ncbi.nlm.nih.gov/pmc/articles/instance/2823848/bin/nihms156136f4.gif)
Similar articles
-
GABAergic neurons immunoreactive for calcium binding proteins are reduced in the prefrontal cortex in major depression.Neuropsychopharmacology. 2007 Feb;32(2):471-82. doi: 10.1038/sj.npp.1301234. Epub 2006 Oct 25. Neuropsychopharmacology. 2007. PMID: 17063153 Free PMC article.
-
Selective deficits in prefrontal cortical GABAergic neurons in schizophrenia defined by the presence of calcium-binding proteins.Biol Psychiatry. 2002 Oct 1;52(7):708-15. doi: 10.1016/s0006-3223(02)01360-4. Biol Psychiatry. 2002. PMID: 12372661
-
Calcium-binding proteins in focal cortical dysplasia.Epilepsia. 2015 Aug;56(8):1207-16. doi: 10.1111/epi.13053. Epub 2015 Jun 17. Epilepsia. 2015. PMID: 26081613 Free PMC article.
-
N-methyl-D-aspartate receptor and calbindin-containing neurons in the anterior cingulate cortex in schizophrenia and bipolar disorder.Biol Psychiatry. 2008 Nov 1;64(9):803-9. doi: 10.1016/j.biopsych.2008.04.034. Epub 2008 Jun 30. Biol Psychiatry. 2008. PMID: 18585682 Free PMC article.
-
Postnatal development of calcium-binding proteins immunoreactivity (parvalbumin, calbindin, calretinin) in the human entorhinal cortex.J Chem Neuroanat. 2003 Dec;26(4):311-6. doi: 10.1016/j.jchemneu.2003.09.005. J Chem Neuroanat. 2003. PMID: 14729133 Review.
Cited by
-
GABAA Receptor Availability in Relation to Cortical Excitability in Depressed and Healthy: A Positron Emission Tomography and Transcranial Magnetic Stimulation Study.Neuropsychobiology. 2024;83(1):17-27. doi: 10.1159/000535512. Epub 2023 Dec 27. Neuropsychobiology. 2024. PMID: 38151012 Free PMC article.
-
Social isolation leads to mild social recognition impairment and losses in brain cellularity.Brain Struct Funct. 2023 Dec;228(9):2051-2066. doi: 10.1007/s00429-023-02705-z. Epub 2023 Sep 10. Brain Struct Funct. 2023. PMID: 37690044
-
Brain-wide changes in excitation-inhibition balance of major depressive disorder: a systematic review of topographic patterns of GABA- and glutamatergic alterations.Mol Psychiatry. 2023 Aug;28(8):3257-3266. doi: 10.1038/s41380-023-02193-x. Epub 2023 Jul 26. Mol Psychiatry. 2023. PMID: 37495889
-
The long-term effects of maternal deprivation on the number and size of inhibitory interneurons in the rat amygdala and nucleus accumbens.Front Neurosci. 2023 Jun 26;17:1187758. doi: 10.3389/fnins.2023.1187758. eCollection 2023. Front Neurosci. 2023. PMID: 37434764 Free PMC article.
-
A review of critical brain oscillations in depression and the efficacy of transcranial magnetic stimulation treatment.Front Psychiatry. 2023 May 16;14:1073984. doi: 10.3389/fpsyt.2023.1073984. eCollection 2023. Front Psychiatry. 2023. PMID: 37260762 Free PMC article. Review.
References
-
- Sanacora G, Saricicek A. GABAergic contributions to the pathophysiology of depression and the mechanism of antidepressant action. CNS Neurol Disord Drug Targets. 2007;6:127–140. - PubMed
-
- Sanacora G, Mason GF, Rothman DL, Behar KL, Hyder F, Petroff OA, et al. Reduced cortical γ-aminobutyric acid levels in depressed patients determined by proton magnetic resonance spectroscopy. Arch Gen Psychiatry. 1999;56:1043–1047. - PubMed
-
- Sanacora G, Gueorguieva R, Epperson CN, Wu YT, Appel M, Rothman DL, Krystal JH. Subtype-specific alterations of GABA and glutamate in major depression. Arch Gen Psychiatry. 2004;61:705–713. - PubMed
-
- Hasler G, van der Veen JW, Tumonis T, Meyers N, Shen J, Drevets WC. Reduced prefrontal glutamate/glutamine and gamma-aminobutyric acid levels in major depression determined using proton magnetic resonance spectroscopy. Arch Gen Psychiatry. 2007;64:193–200. - PubMed
-
- Bhagwagar Z, Wylezinska M, Jezzard P, Evans J, Ashworth F, Sule A, Matthews PM, Cowen PJ. Reduction in occipital cortex gamma-aminobutyric acid concentrations in medication-free recovered unipolar depressed and bipolar subjects. Biol Psychiatry. 2007;61:806–812. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
- P20 RR017701-07/RR/NCRR NIH HHS/United States
- MH67996/MH/NIMH NIH HHS/United States
- R01 MH071676-04/MH/NIMH NIH HHS/United States
- RR17701/RR/NCRR NIH HHS/United States
- R01 MH071676/MH/NIMH NIH HHS/United States
- R01 MH067996-03S1/MH/NIMH NIH HHS/United States
- K02 MH076222-02/MH/NIMH NIH HHS/United States
- R01 MH067996/MH/NIMH NIH HHS/United States
- P20 RR017701-076629/RR/NCRR NIH HHS/United States
- P50 MH060451/MH/NIMH NIH HHS/United States
- MH60451/MH/NIMH NIH HHS/United States
- K02 MH076222/MH/NIMH NIH HHS/United States
- P50 MH060451-01A20002/MH/NIMH NIH HHS/United States
- P20 RR017701/RR/NCRR NIH HHS/United States
- MH076222/MH/NIMH NIH HHS/United States
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical